Medical Perspectives on Autism Spectrum Disorders

ABSTRACTS

This article provides a general overview of the current diagnostic criteria and methodology for identifying children with autism. It addresses an apparent increase in the prevalence of autism and potential contributing factors to this increase. A discussion on therapeutic modalities available for the treatment of autism is offered. The roles of pediatricians and the care of children with autistic spectrum disorders, as part of an interdisciplinary team, are highlighted.

KEYWORDS

Autism spectrum disorders - Asperger disorder - applied behavioral analysis

REFERENCES

• 1 Kanner L. Autistic disturbances of affective contact.  Nervous Child. 1943;  2 217-250
• 2 American Psychiatric Association .Diagnostic and Statistical Manual of Mental Disorders. Washington, DC; APA 1980
• 3 American Psychiatric Association .Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Washington, DC; APA 1986
• 4 American Psychiatric Association .Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC; APA 1994
• 5 Yeargin-Alsopp M, Reiss C, Karapurkar T et al.. Prevalence of autism in a US metropolitan area.  JAMA. 2003;  289 49-55
• 6 Bertrand J, Mars A, Boyle C et al.. Prevalence of autism in a United States population: the Brick Township, New Jersey, investigation.  Pediatrics. 2001;  108 1155-1161
• 7 Chakrabarti S, Fombonne E. Pervasive developmental disorders in preschool children.  JAMA. 2001;  285 3093-3099
• 8 Barbaresi W R, Katusic S K, Collagen R C et al.. Explaining the apparent increase in the incidence of autism in Olmstead County Minnesota from 1976 to 1997.  J Dev Behav Pediatr. 2002;  23 398-399
• 9 Barton M, Volkmar F. How commonly are known medical conditions associated with autism?.  J Autism Dev Disord. 1998;  28 273-278
• 10 Bailey A, Luthert P, Dean A et al.. A clinicopathological study of autism.  Brain. 1998;  121 889-905
• 11 Kemper T L, Bauman M. Neuropathology of infantile autism.  J Neuropathol Exp Neurol. 1998;  57 645-652
• 12 Nelson K B, Grether J K, Crien L A et al.. Neuropeptides and neurotrophins in neonatal blood of children with autism or mental retardation.  Ann Neurol. 2001;  49 597-606
• 13 Baron-Cohen S, Allen J, Gillberg C. Can autism be detected at 18 months? The needle, the haystack, and the CHAT.  Br J Psychiatry. 1992;  161 839-843
• 14 Siegel B. Pervasive Developmental Disorders Screening Test-II. San Antonio, TX; Harcourt Publishing 2004
• 15 Robins D L, Fein D, Barton M L, Green J A. The modified checklist for autism in toddlers: an initial study investigating the early detection of autism and pervasive developmental disorders.  J Autism Dev Disord. 2001;  31(2) 131-144
• 16 Schopler E, Reichler R, Renner B R. The Childhood Autism Rating Scale (CARS). Austin, TX; Pro-Ed 1988
• 17 Gilliam J E. Gilliam Autism Rating Scale (GARS). Austin, TX; Pro-Ed 1995
• 18 Rutter M, Le Couteur A, Lord C. ADI-R Autism Diagnostic Interview-Revised. Los Angeles, CA; Western Psychological Services 2003
• 19 Lord C, Rutter M L, Goode S et al.. Autism Diagnostic Observation Schedule: A standardized observation of communicative and social behavior.  J Autism Dev Disord. 1989;  19(2) 185-212
• 20 Lovaas O I. Behavioral treatment and normal educational and intellectual functioning in young autistic children.  J Consult Clin Psychol. 1997;  55 3-9
• 21 Wieder S, Greenspan S I. Climbing the symbolic ladder in the DIR model through floor time/interactive play.  Autism. 2003;  7(4) 425-435
• 22 Aman M G, Van Bourgondien M E, Wolford P L, Sarphare G. Psychotropic and anticonvulsant drugs in subjects with autism: prevalence and patterns of use.  J Am Acad Child Adolec Psychiatry. 1995;  34 1672-1681
• 23 Langworthy-Lam K S, Aman M G, Van Bourgondien M E. Prevalence and patterns of use of psychoactive medicines in individuals with autism in the Autism Society of North Carolina.  J Child Adolesc Psychiatry. 2002;  12 311-321
• 24 Research Units on Pediatric Psychopharmacology Autism Network . Risperidone in children with autism and serious behavioral disturbances.  N Engl J Med. 2002;  347 314-321
• 25 McDougale C J, Naylor S T, Cohen C J et al.. A double-blind, placebo-controlled study all flew Fox a mean in adults with autistic disorder.  Arch Gen Psychiatry. 1996;  53 1001-1008
• 26 American Academy of Pediatrics .Complementary and alternative medicine. Available at: http://www.aap.org/visit/tfocam.htm Accessed October 14, 2005
• 27 Aman M G, Singh N N. Vitamin, mineral, in dietary treatment. In: Aman MG, Singh NN Psychopharmacology of the Developmental Disabilities. New York; Springer-Verlag 1998: 168-196
• 28 Kleijnen J, Knipschild P. Niacin and vitamin B-6 in mental functioning: a review of controlled trials in humans.  Biol Psychiatry. 1991;  29 931-941
• 29 Tolbert L, Haigler T, Waits M M, Dennis T. Brief report: lack of response in an autistic population to a low dose clinical trial of pyridoxine plus magnesium.  J Autism Dev Disord. 1993;  23 193-199
• 30 Findling R L, Maxwell K, Scotese-Wojtila L, Huang J, Yamashita T, Witznitzer M. High-dose pyridoxine and magnesium administration in children with autistic disorder: an absence of salutatory effects in a double-blind placebo-controlled study.  J Autism Dev Disord. 1997;  27 467-478
• 31 Knivsberg A M, Reichelt K L, Hoien T, Nodland M. A randomized, controlled study of dietary intervention in autistic syndromes.  Nutr Neurosci. 2002;  5 251-261
• 32 Sponheim E. Gluten-free diet in infantile autism: a therapeutic trial.  Tidsskrift for Den Norske Laegeforening. 1991;  111 704-707
• 33 Wakefield A J, Murch S H, Anthony A et al.. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and perseverative developmental disorder in children.  Lancet. 1998;  351 637-641
• 34 Murch S H, Anthony A, Casson D H et al.. Retraction of an interpretation.  Lancet. 2004;  363(9411) 750
• 35 Stratton K. Immunization safety review: thimerosal-containing vaccines and neurodevelopmental disorders. Washington, DC; National Academy Press 2001
• 36 Lord C. Is secretin a useful treatment in autism?.  J Autism Devel Disord. 1999;  29 269